Zacks.com featured highlights include Amicus Therapeutics, Micron Technology and General Dynamics

07.10.25 14:34 Uhr

Werte in diesem Artikel
Aktien

8,45 EUR 0,00 EUR 0,00%

294,00 EUR 1,35 EUR 0,46%

195,94 EUR 1,72 EUR 0,89%

Indizes

PKT PKT

PKT PKT

25.256,3 PKT 237,9 PKT 0,95%

18.057,5 PKT 245,5 PKT 1,38%

3.425,2 PKT 25,7 PKT 0,76%

6.820,4 PKT 54,5 PKT 0,81%

For Immediate ReleaseChicago, IL – October 7, 2025 – Stocks in this week’s article are Amicus Therapeutics, Inc. FOLD, Micron Technology Inc. MU and General Dynamics Corp. GD.Bet on These 3 Stocks with Upgraded Broker Ratings for Solid ReturnsInvestor sentiments are bullish of late despite tariff policies resulting in higher inflation. Last month, the Federal Reserve lowered interest rates for the first time this year amid a continued deterioration in the labor market. Amid such a backdrop, retail investors face massive challenges in picking the right stocks and generating robust returns.One way to cut short this task is to follow brokers' recommendations. In this regard, stocks such as Amicus Therapeutics, Inc., Micron Technology Inc. and General Dynamics Corp. are worth considering for investment.Brokers often develop deeper insights into companies by engaging directly with senior management, reviewing public filings, and participating in earnings calls. Their sector-wide perspective enables them to assess company fundamentals within the broader context of economic conditions, offering a clearer view of how a stock may perform as an investment.That said, a broker's stock upgrade can be a useful signal but should not serve as the sole basis for portfolio decisions. Achieving consistent, long-term returns requires investors to weigh factors beyond broker recommendations.3 Stocks with Upgraded Broker Ratings to Bet OnPrinceton, NJ-based Amicus Therapeutics is a global patient-centric biotechnology company. FOLD is engaged in discovering, developing and commercializing various novel treatments for patients with rare metabolic diseases.Amicus Therapeutics' 2025 earnings are expected to jump 29.2% year over year. FOLD, which currently carries a Zacks Rank #2, has witnessed a 7.7% upward revision in broker ratings over the past four weeks.Micron, based in Boise, ID, is one of the leading worldwide providers of semiconductor memory solutions. MU's mission is to be the most efficient and innovative global provider of semiconductor memory solutions.MU's fiscal 2026 earnings are projected to surge 100% on a year-over-year basis. Micron, sporting a Zacks Rank #1 at present, has witnessed a 2.7% upward revision in broker ratings over the past four weeks.Based in Reston, VA, General Dynamics engages in mission-critical information systems and technologies; land and expeditionary combat vehicles, armaments and munitions; shipbuilding and marine systems; and business aviation. GD operates through four segments — Aerospace, Combat Systems, Marine Systems and Technologies.General Dynamics' 2025 earnings are expected to rise 11.7% year over year. GD, currently carrying a Zacks Rank #2, has witnessed a 4.8% upward revision in broker ratings over the past four weeks.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial of the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2762607/bet-on-these-3-stocks-with-upgraded-broker-ratings-for-solid-returnsDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report General Dynamics Corporation (GD): Free Stock Analysis Report Micron Technology, Inc. (MU): Free Stock Analysis Report Amicus Therapeutics, Inc. (FOLD): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Amicus Therapeutics und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Amicus Therapeutics

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Amicus Therapeutics

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Micron Technology Inc.

Wer­bung

Analysen zu Micron Technology Inc.

DatumRatingAnalyst
26.06.2025Micron Technology OverweightBarclays Capital
19.12.2024Micron Technology BuyUBS AG
26.09.2024Micron Technology BuyGoldman Sachs Group Inc.
27.06.2024Micron Technology BuyUBS AG
21.12.2023Micron Technology BuyUBS AG
DatumRatingAnalyst
26.06.2025Micron Technology OverweightBarclays Capital
19.12.2024Micron Technology BuyUBS AG
26.09.2024Micron Technology BuyGoldman Sachs Group Inc.
27.06.2024Micron Technology BuyUBS AG
21.12.2023Micron Technology BuyUBS AG
DatumRatingAnalyst
08.04.2019Micron Technology Market PerformCowen and Company, LLC
19.12.2018Micron Technology HoldNeedham & Company, LLC
19.12.2018Micron Technology Sector PerformRBC Capital Markets
28.11.2017Micron Technology HoldStandpoint Research
13.12.2016Micron Technology HoldLoop Capital
DatumRatingAnalyst
24.05.2017Micron Technology ReduceStandpoint Research
10.06.2011Micron Technology sellGoldman Sachs Group Inc.
09.12.2008Micron Technology NeueinschätzungGoldman Sachs Group Inc.
29.09.2008Micron Technology ErsteinschätzungJMP Securities LLC
04.04.2008Micron Technology below averageCaris & Company, Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Micron Technology Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen